NCT01018394View on ClinicalTrials.gov

Nicotine Lozenge or Tobacco-Free Snuff for Smokeless Tobacco Reduction

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

81

Participants

Timeline

Start Date

January 31, 2009

Primary Completion Date

July 31, 2012

Study Completion Date

July 31, 2012

Conditions
Tobacco Dependence
Interventions
DRUG

nicotine lozenges

4 mg nicotine lozenges for a maximum duration of 12 weeks used ad lib - up to 8 nicotine lozenges per day.

DRUG

tobacco-free snuff

Tobacco-free snuff used ad lib for a maximum of 12 weeks

Trial Locations (2)

55905

Mayo Clinic, Rochester

97403

Oregon Research Institute, Eugene

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

lead

Mayo Clinic

OTHER